Form 4: Molina Healthcare Director Ronna Romney Receives Scheduled Equity Grant

Molina Healthcare, Inc. Director Ronna Romney was granted 180 shares of common stock valued at $306.29 per share as part of her director compensation under the 2025 Equity Incentive Plan.

Summary

• Director Ronna Romney acquired 180 shares of Molina Healthcare, Inc. common stock.
• The transaction occurred on July 1, 2025, as a pre-scheduled grant.
• The shares were granted at a price of $306.29 per share, which was the closing price of the common stock on the transaction date.
• This grant is part of the Issuer's 2025 Equity Incentive Plan, compensating her for services as a Director.
• The annual equity award for directors is set at $220,000, with one quarter, or $55,000, granted on the first day of each quarter.
• Following this transaction, Ronna Romney beneficially owns 17,831 shares, held indirectly by the Ronna Romney Revocable Trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-scheduled equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. There are no negative or significantly positive surprises.

Positives

• The grant of shares to a director aligns with standard corporate governance practices for compensating board members.
• The equity incentive plan encourages alignment of director interests with long-term shareholder value.

Future Outlook

The filing indicates a future transaction date of July 1, 2025, reflecting a pre-scheduled equity grant under the company's 2025 Equity Incentive Plan, suggesting a continued compensation structure for directors.

Management Comments

• The aggregate dollar value of the annual equity award to each director was set at $220,000.
• One quarter, or $55,000, is to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day.

Industry Context

This routine director equity grant is a common practice in the healthcare industry and publicly traded companies generally, serving to align the interests of board members with long-term shareholder value. It reflects standard compensation practices for non-employee directors.

Comparison to Industry Standards

• Director compensation, particularly through equity grants, is a standard practice across publicly traded companies, including those in the healthcare sector.
• While specific compensation figures vary by company size, performance, and industry benchmarks, the structure of granting shares under an equity incentive plan is consistent with global corporate governance best practices.
• For example, companies like UnitedHealth Group (UNH) and Elevance Health (ELV) also utilize equity-based compensation for their non-employee directors to foster long-term alignment.

Corporate Governance

Related Party Transactions

• The 17,831 shares beneficially owned by Ronna Romney are held indirectly by the Ronna Romney Revocable Trust.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with long-term shareholder value.
• Management/Directors: The grant represents a component of director compensation, incentivizing continued service and performance.

Next Steps

• Future quarterly equity grants to directors under the 2025 Equity Incentive Plan are expected to continue as per the established schedule.

Key Dates

Keywords

Molina Healthcare, MOH, Ronna Romney, SEC Form 4, Insider Transaction, Stock Grant, Equity Incentive Plan, Director Compensation, Common Stock, Beneficial Ownership